New lupus pill tested for safety in chinese patients
NCT ID NCT07266090
Summary
This study aims to learn about the safety and how the body processes a new daily pill called cenerimod in Chinese adults with moderate-to-severe lupus. Participants will take the pill for up to a year while continuing their current lupus medications. The main goal is to check for side effects and see how the drug behaves in the body, not to prove it treats lupus symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SLE - SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
First Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, 471003, China
-
First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, 330200, China
-
First People's Hospital of Jiujiang
Jiujiang, Jiangxi, 332000, China
-
Peking Union Medical College Hospital
Beijing, 100010, China
-
The First Affiliated Hospital Of Jinan University
Guangzhou, Guangdong, 510630, China
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, 450052, China
-
The Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, 050000, China
Conditions
Explore the condition pages connected to this study.